You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

NEBUPENT Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Nebupent, and when can generic versions of Nebupent launch?

Nebupent is a drug marketed by Fresenius Kabi Usa and is included in one NDA.

The generic ingredient in NEBUPENT is pentamidine isethionate. There are fourteen drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the pentamidine isethionate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Nebupent

A generic version of NEBUPENT was approved as pentamidine isethionate by SETON PHARMS on September 28th, 2017.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for NEBUPENT?
  • What are the global sales for NEBUPENT?
  • What is Average Wholesale Price for NEBUPENT?
Summary for NEBUPENT
US Patents:0
Applicants:1
NDAs:1
Finished Product Suppliers / Packagers: 1
Raw Ingredient (Bulk) Api Vendors: 104
Clinical Trials: 1
Patent Applications: 1,629
What excipients (inactive ingredients) are in NEBUPENT?NEBUPENT excipients list
DailyMed Link:NEBUPENT at DailyMed
Drug patent expirations by year for NEBUPENT
Recent Clinical Trials for NEBUPENT

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of Illinois at Chicago

See all NEBUPENT clinical trials

Pharmacology for NEBUPENT
Drug ClassAntiprotozoal

US Patents and Regulatory Information for NEBUPENT

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fresenius Kabi Usa NEBUPENT pentamidine isethionate FOR SOLUTION;INHALATION 019887-001 Jun 15, 1989 AN RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Fresenius Kabi Usa NEBUPENT pentamidine isethionate FOR SOLUTION;INHALATION 019887-002 Mar 22, 1996 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.